デフォルト表紙
市場調査レポート
商品コード
995274

患者エンゲージメントソリューションの世界市場:配信タイプ別、コンポーネント(ソフトウェア、サービス)別、最終用途別、アプリケーション別、治療領域別、地域別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2028年)

Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type, By Component (Software, Services), By End-use, By Application, By Therapeutic Area, By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 120 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.49円
患者エンゲージメントソリューションの世界市場:配信タイプ別、コンポーネント(ソフトウェア、サービス)別、最終用途別、アプリケーション別、治療領域別、地域別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2028年)
出版日: 2021年02月25日
発行: Grand View Research, Inc.
ページ情報: 英文 120 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の患者エンゲージメントソリューションの市場規模は、2021年から2028年にかけて21.4%のCAGRで拡大し、2028年までに705億米ドルに達すると予想されています。

m-healthの採用、糖尿病、喘息、関節炎などの慢性疾患の有病率の増加、ヘルスケアサービスの改善、患者教育の向上、患者データの追跡、および診断治療などにより、市場は指数関数的な成長を記録しする見通しです。

2021年1月、バイデン・ハリス政権は「特別加入期間」を設けました。この法的措置の下で、米国人は健康保険に加入でき、メディケイド、医療費負担適正化法、およびリプロダクティブヘルスケアの利用に対する攻撃は撃退させられます。したがって、そのような行政命令によって、COVID-19の発生で形成された医療要件が満たされ、リプロダクティブヘルスケアの利用が保護され、医療制度がより簡単で偏りのないものになります。このようなイニシアチブは、予測期間にわたってこれらのサービスの需要を促進すると予想されます。

当レポートでは、世界の患者エンゲージメントソリューション市場について調査分析し、市場および業界の見通し、セグメント別・地域別の見通しのほか、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場細分化と範囲
  • 調査方法
  • 情報の取得
  • 情報またはデータ分析
  • 市場の定式化と検証
  • モデルの詳細
  • 二次資料のリスト
  • 一次資料のリスト
  • 略語
  • 目的

第2章 エグゼクティブサマリー

第3章 患者エンゲージメントソリューションの市場変数の動向と範囲

  • 市場系統の見通し
  • テクノロジー別浸透と成長の見通しのマッピング、2020年
  • ユーザーの視点分析
  • 規制の枠組み
  • テクノロジーの概要
  • 市場力学
  • 業界分析-ポーターのファイブフォース分析
  • 患者エンゲージメントソリューション-要因別のSWOT分析(政治的および法的、経済的、社会的および技術的)
  • 主要な取引と戦略的提携の分析
  • 市場参入戦略

第4章 患者エンゲージメントソリューション市場:競合分析

  • 市場参加の分類
  • ベンダー情勢
    • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要企業の市場シェア分析、2020年
  • 公開企業
    • 企業の市況分析(収益、地理的プレゼンス、製品ポートフォリオ、主要なサービス可能な業界、主要な提携)
    • 市場の差別化要因
    • 相乗効果分析:主要な取引と戦略的提携
  • 非公開企業
    • 主要な新興企業の/テクノロジーディスラプター/イノベーターのリスト
    • 地域ネットワークマップ
  • 主要顧客
    • 主要な購入者のリスト
  • 潜在的なターゲットオーディエンス

第5章 患者エンゲージメントソリューション市場:配信タイプ別

  • 配信タイプ別市場分析

第6章 患者エンゲージメントソリューション市場:コンポーネント別

  • コンポーネント別市場分析

第7章 患者エンゲージメントソリューション市場:最終用途別

  • 最終用途別市場分析

第8章 患者エンゲージメントソリューション市場:アプリケーション別

  • アプリケーション別市場分析

第9章 患者エンゲージメントソリューション市場:治療領域別

  • 治療領域別市場分析

第10章 患者エンゲージメントソリューション:地域市場分析(アプリケーション、テクノロジー、および最終用途別)、2016年~2028年(百万米ドル)

  • 地域別市場シェア分析、2020年および2028年
  • 地域別市場のダッシュボード
  • 地域別市場のスナップショット
  • 市場規模、および予測と動向分析、2020年~2028年
    • 北米
    • 米国
    • カナダ
    • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • ラテンアメリカ
    • ブラジル
    • メキシコ
    • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア

第11章 企業プロファイル

  • Allscripts Healthcare Solutions
  • McKesson Corporation
  • Orion Health Ltd.
  • Cerner Corporation
  • Phytel Inc.
  • Medecision Inc.
  • GetWellNetwork Inc.
  • YourCareUniverse Inc.
  • Lincor Solutions Ltd.
  • Athenahealth, Inc.
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of key emerging companies
  • Table 3. Patient Engagement Solutions - Industry Snapshot
  • Table 4. Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 5. Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 6. Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 7. Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 8. Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 9. Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 10. Patient Engagement Solutions Market - Key Market driver's analysis
  • Table 11. Patient Engagement Solutions Market - Key Market restraints analysis
  • Table 12. North America Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 13. North America Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 14. North America Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 15. North America Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 16. North America Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 17. North America Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 18. U.S. Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 19. U.S. Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 20. U.S. Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 21. U.S. Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 22. U.S. Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 23. Canada Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 24. Canada Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 25. Canada Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 26. Canada Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 27. Canada Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 28. Europe Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 29. Europe Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 30. Europe Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 31. Europe Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 32. Europe Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 33. Europe Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 34. U.K. Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 35. U.K. Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 36. U.K. Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 37. U.K. Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 38. U.K. Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 39. Germany Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 40. Germany Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 41. Germany Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 42. Germany Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 43. Germany Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 44. France Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 45. France Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 46. France Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 47. France Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 48. France Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 49. Italy Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 50. Italy Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 51. Italy Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 52. Italy Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 53. Italy Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 54. Spain Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 55. Spain Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 56. Spain Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 57. Spain Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 58. Spain Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 59. Netherlands Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 60. Netherlands Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 61. Netherlands Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 62. Netherlands Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 63. Netherlands Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 64. Sweden Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 65. Sweden Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 66. Sweden Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 67. Sweden Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 68. Sweden Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 69. Russia Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 70. Russia Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 71. Russia Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 72. Russia Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 73. Russia Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 74. Asia Pacific Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 75. Asia Pacific Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 76. Asia Pacific Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 77. Asia Pacific Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 78. Asia Pacific Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 79. Asia Pacific Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 80. Japan Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 81. Japan Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 82. Japan Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 83. Japan Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 84. Japan Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 85. China Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 86. China Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 87. China Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 88. China Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 89. China Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 90. India Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 91. India Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 92. India Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 93. India Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 94. India Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 95. Latin America Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 96. Latin America Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 97. Latin America Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 98. Latin America Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 99. Latin America Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 100. Latin America Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 101. Brazil Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 102. Brazil Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 103. Brazil Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 104. Brazil Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 105. Brazil Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 106. Mexico Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 107. Mexico Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 108. Mexico Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 109. Mexico Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 110. Mexico Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 111. MEA Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 112. MEA Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 113. MEA Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 114. MEA Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 115. MEA Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 116. MEA Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 117. South Africa Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 118. South Africa Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 119. South Africa Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 120. South Africa Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 121. South Africa Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 122. Saudi Arabia Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 123. Saudi Arabia Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 124. Saudi Arabia Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 125. Saudi Arabia Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 126. Saudi Arabia Patient Engagement Solutions Market, By Therapeutic Area, (USD Million)

List of Figures

  • Fig. 1 Patient Engagement Solutions Market Segmentation
  • Fig. 2 Global Patient Engagement Solutions Market Revenue, 2016 - 2028
  • Fig. 3 Patient Engagement Solutions Market Dynamics
  • Fig. 4 Key Opportunities Prioritized
  • Fig. 5 Patient Engagement Solutions Market Analysis - Porter's
  • Fig. 6 Patient Engagement Solutions Market Analysis - PESTEL Analysis
  • Fig. 7 Global Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 8 Global Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 9 Global Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 10 Global Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 11 Global Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 12 Delivery Type Market, 2016 to 2028 (USD Million)
  • Fig. 13 Web/Cloud-Based Delivery Market, 2016 to 2028 (USD Million)
  • Fig. 14 On-premise Delivery Market, 2016 to 2028 (USD Million)
  • Fig. 15 Component Market, 2016 to 2028 (USD Million)
  • Fig. 16 Software Market, 2016 to 2028 (USD Million)
  • Fig. 17 Services Market, 2016 to 2028 (USD Million)
  • Fig. 18 Hardware Market, 2016 to 2028 (USD Million)
  • Fig. 19 End-Use Market, 2016 to 2028 (USD Million)
  • Fig. 20 Payers Market, 2016 to 2028 (USD Million)
  • Fig. 21 Providers Market, 2016 to 2028 (USD Million)
  • Fig. 22 Individual users Market, 2016 to 2028 (USD Million)
  • Fig. 23 Application Market, 2016 to 2028 (USD Million)
  • Fig. 24 Social Management Market, 2016 to 2028 (USD Million)
  • Fig. 25 Health Management Market, 2016 to 2028 (USD Million)
  • Fig. 26 Home Healthcare Management Market, 2016 to 2028 (USD Million)
  • Fig. 27 Financial Health Management Market, 2016 to 2028 (USD Million)
  • Fig. 28 Therapeutic Area Market, 2016 to 2028 (USD Million)
  • Fig. 29 Chronic Diseases Market, 2016 to 2028 (USD Million)
  • Fig. 30 Women's Health Market, 2016 to 2028 (USD Million)
  • Fig. 31 Fitness Market, 2016 to 2028 (USD Million)
  • Fig. 32 Mental Health Market, 2016 to 2028 (USD Million)
  • Fig. 33 Others Market, 2016 to 2028 (USD Million)
  • Fig. 34 Global Patient Engagement Solutions Market, By region 2016 to 2028 (USD Million)
  • Fig. 35 North America Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 36 North America Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 37 North America Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 38 North America Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 39 North America Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 40 U.S. Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 41 U.S. Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 42 U.S. Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 43 U.S. Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 44 U.S. Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 45 Canada Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 46 Canada Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 47 Canada Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 48 Canada Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 49 Canada Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 50 Europe Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 51 Europe Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 52 Europe Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 53 Europe Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 54 Europe Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 55 U.K. Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 56 U.K. Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 57 U.K. Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 58 U.K. Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 59 U.K. Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 60 Germany Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 61 Germany Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 62 Germany Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 63 Germany Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 64 Germany nada Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 65 Spain Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 66 Spain Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 67 Spain Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 68 Spain Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 69 Spain Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 70 France Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 71 France Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 72 France Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 73 France Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 74 France Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 75 Italy Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 76 Italy Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 77 Italy Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 78 Italy Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 79 Italy Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 80 Sweden Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 81 Sweden Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 82 Sweden Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 83 Sweden Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 84 Sweden Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 85 Netherlands Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 86 Netherlands Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 87 Netherlands Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 88 Netherlands Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 89 Netherlands Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 90 Russia Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 91 Russia Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 92 Russia Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 93 Russia Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 94 Russia Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 95 APAC Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 96 APAC Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 97 APAC Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 98 APAC Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 99 APAC Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 100 China Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 101 China Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 102 China Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 103 China Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 104 China Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 105 Japan Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 106 Japan Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 107 Japan Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 108 Japan Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 109 Japan Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 110 India Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 111 India Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 112 India Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 113 India Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 114 India Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 115 LATAM Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 116 LATAM Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 117 LATAM Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 118 LATAM Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 119 LATAM Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 120 Mexico Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 121 Mexico Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 122 Mexico Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 123 Mexico Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 124 Mexico Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 125 Brazil Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 126 Brazil Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 127 Brazil Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 128 Brazil Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 129 Brazil Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 130 MEA Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 131 MEA Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 132 MEA Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 133 MEA Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 134 MEA Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 135 South Africa Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 136 South Africa Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 137 South Africa Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 138 South Africa Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 139 South Africa Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 140 Saudi Arabia Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 141 Saudi Arabia Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 142 Saudi Arabia Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 143 Saudi Arabia Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 144 Saudi Arabia Market, By Therapeutic Area, 2016 to 2028 (USD Million)
目次
Product Code: GVR-1-68038-024-8

Patient Engagement Solutions Market Growth & Trends

The global patient engagement solutions market size is expected to reach USD 70.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.4% from 2021 to 2028. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment.

In January 2021, the Biden-Harris administration opened a "Special Enrollment Period". Under this action, Americans to sign up for health coverage and roll back attacks on the Medicaid, Affordable Care Act, and access to reproductive health care. Hence, such orders meet the healthcare requirements formed by the COVID-19 outbreak, it will protect access to reproductive health care, and make health care system easier and more unbiassed. Such initiatives are anticipated to drive the demand for these services over the forecast period.

As healthcare providers were battling with the constant upsurge in numerous cases, patients were looking to digital technologies for the support which promoted the adoption of a product. The outbreak has resulted in the introduction of multiple COVID-19- related features patient engagement solutions by various players. The growing number of smartphone users around the globe expedited the adoption of mHealth across the sector both from providers and consumers which in turn, has augmented the dependability of patients on mHealth apps.

Moreover, in March 2019, the American Medical Association entered a collaboration with Patient Point with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using Patient Point technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period.

The necessity of social distancing resulted in the demand for remote patient monitoring solutions along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19- related features into their existing patient engagement solutions. For instance, in 2020, Orion Health has established the first complete pandemic outbreak monitoring platform to control the spread of the coronavirus. Hence, it led to the adoption of the solutions.

Patient Engagement Solutions Market Report Highlights

The web-based/cloud-based emerged as the largest delivery type segment in 2020 and accounted for over 80.0% revenue share as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access

The software segment dominated the market in 2020, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions

Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years

The chronic diseases segment dominated the market in 2020 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data

North America dominated the market in 2020 owing to increased adoption of m-health and Electronic Health Record (EHR) and growing investments in patient engagement software by major companies

Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
    • 1.10.3 Market Definitions

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Outlook
  • 2.4 Pateint Engagement Solutions Market Summary, 2020

Chapter 3 Patient Engagement Solutions Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping by Technology, 2020
  • 3.3 User Perspective Analysis
    • 3.3.1 Buyer's Preference Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 Regulatory Framework
    • 3.4.1 Regulatory Landscape
  • 3.5 Technology Overview
    • 3.5.1 Patient engagement solutions: Adoption rate of changing technology
    • 3.5.2 Timeline with major technology changes
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
    • 3.6.2 Market Restraints Analysis
    • 3.6.3 Industry Challenges
  • 3.7 Industry Analysis - Porter's
  • 3.8 Patient Engagement Solutions - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
  • 3.9 Major Deals & Strategic Alliances Analysis
    • 3.9.1 Joint Ventures
    • 3.9.2 Mergers & Acquisitions
    • 3.9.3 Licensing & Partnership
    • 3.9.4 Technology Collaborations
    • 3.9.5 Strategic Divestments
  • 3.10 Market Entry Strategies

Chapter 4 Patient Engagement Solutions Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
  • 4.3 Key company market share analysis, 2020
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2 Market Differentiators
    • 4.4.3 Synergy Analysis: Major Deals & Strategic Alliances
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies' /technology disruptors/innovators
    • 4.5.2 Regional network map
  • 4.6 Key customers
    • 4.6.1 List of key buyers
  • 4.7 Potential Target Audience

Chapter 5 Patient Engagement Solutions Market: Delivery Type Analysis

  • 5.1 Delivery Type Business Analysis
    • 5.1.1 Web/Cloud-Based
      • 5.1.1.1 Web/cloud-based market estimates and forecasts, 2016 - 2028 (USD Million)
    • 5.1.2 On-Premise
      • 5.1.2.1 On-premise market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 6 Patient Engagement Solutions Market: Component

  • 6.1 Component Analysis
    • 6.1.1 Software
      • 6.1.1.1 Software market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.1.2 Standalone software
      • 6.1.1.2.1 Standalone software market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.1.3 Integrated
      • 6.1.1.3.1 Integrated market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.1.2 Services
      • 6.1.2.1 Services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.2 Consulting Services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.3 Implementation services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.4 Education services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.5 Others services market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.1.2 Hardware
      • 6.1.2.1 Hardware market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 7 Patient Engagement Solutions Market: End-use

  • 7.1 End-use Analysis
    • 7.1.1 Payers
      • 7.1.1.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.1.2 Providers
      • 7.1.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.1.3 Individual Users
      • 7.1.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 8 Patient Engagement Solutions Market: Application

  • 8.1 Application Analysis
    • 8.1.1 Social Management
      • 8.1.1.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.1.2 Health Management
      • 8.1.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.1.3 Home Healthcare Management
      • 8.1.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.1.4 Financial Health Management
      • 8.1.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 9 Patient Engagement Solutions Market: Therapeutic Area

  • 9.1 Application Analysis
    • 9.1.1 Chronic Diseases
      • 9.1.1.1 Chronic diseases market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.2 Obesity
      • 9.1.1.2.1 Obesity market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.3 Diabetes
      • 9.1.1.3.1 Diabetes market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.4 Cardiovascular
      • 9.1.1.4.1 Cardiovascular market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.5 Others
      • 9.1.1.5.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.2 Fitness
      • 9.1.2.1 Fitness market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.3 Women's Health
      • 9.1.3.1 Women's Health market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.4 Mental Health
      • 9.1.4.1 Mental Health market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.5 Others
      • 9.1.5.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 10 Patient Engagement Solutions: Regional Market Analysis, By Application, Technology, and End Use 2016 - 2028 (USD Million)

  • 10.1 Regional Market Share Analysis, 2020 & 2028
  • 10.2 Regional Market Dashboard
  • 10.3 Regional Market Snapshot
  • 10.4 Market Size, & Forecasts and Trend Analysis, 2020 to 2028
    • 10.4.1 North America
    • 10.4.2 Market estimates and segment forecasts, 2016 - 2028 (USD Million)
    • 10.4.3 U.S.
      • 10.4.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.4 Canada
      • 10.4.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.5 Europe
    • 10.4.6 Market estimates And Forecasts By Countries, 2016 - 2028 (USD Million)
    • 10.4.7 U.K.
      • 10.4.7.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.8 Germany
      • 10.4.8.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.9 France
      • 10.4.9.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.10 Italy
      • 10.4.10.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.11 Spain
      • 10.4.11.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.12 Netherlands
      • 10.4.12.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.13 Sweden
      • 10.4.13.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.13 Russia
      • 10.4.13.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.14 Asia Pacific
    • 10.4.15 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.16 Japan
      • 10.4.16.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.17 China
      • 10.4.17.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.18 India
      • 10.4.18.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.19 Latin America
    • 10.4.20 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.21 Brazil
      • 10.4.21.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.22 Mexico
      • 10.4.22.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.23 MEA
    • 10.4.24 Market estimates and forecasts by countries, 2016 - 2028 (USD Million)
    • 10.4.25 South Africa
      • 10.4.25.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.26 Saudi Arabia
      • 10.4.26.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 11 Company Profiles

  • 11.1 Allscripts Healthcare Solutions
    • 11.1.1 Company Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Benchmarking
    • 11.1.4 Strategic Initiatives
  • 11.2 McKesson Corporation
    • 11.2.1 Company Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Benchmarking
    • 11.2.4 Strategic Initiatives
  • 11.3 Orion Health Ltd.
    • 11.3.1 Company Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Benchmarking
    • 11.3.4 Strategic Initiatives
  • 11.4 Cerner Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Benchmarking
    • 11.4.4 Strategic Initiatives
  • 11.5 Phytel Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Benchmarking
    • 11.5.4 Strategic Initiatives
  • 11.6 Medecision Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Benchmarking
    • 11.6.4 Strategic Initiatives
  • 11.7 GetWellNetwork Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Benchmarking
    • 11.7.4 Strategic Initiatives
  • 11.8 YourCareUniverse Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Benchmarking
    • 11.8.4 Strategic Initiatives
  • 11.9 Lincor Solutions Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Benchmarking
    • 11.9.4 Strategic Initiatives
  • 11.10 Athenahealth, Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Benchmarking
    • 11.10.4 Strategic Initiatives